Status:
COMPLETED
GORE® EXCLUDER® Endoprosthesis French Mandatory Registry
Lead Sponsor:
W.L.Gore & Associates
Conditions:
Abdominal Aortic Aneurysm
Eligibility:
All Genders
18+ years
Brief Summary
This is a French Registry mandated by the French National Health Authority assessing long-term (5-years) safety of the GORE® Excluder® Endoprosthesis in the treatment of infra-renal Abdominal Aortic A...
Detailed Description
The use of abdominal aortic endoprostheses makes the treatment of infra-renal abdominal aortic aneurysms possible, with implantation via the femoral artery, thus avoiding a very invasive surgical proc...
Eligibility Criteria
Inclusion
- Any patients requiring abdominal aortic stenting for the treatment of an unruptured infra-renal aortic abdominal aneurysm.
Exclusion
- Patients whose clinical follow-up is not possible, i.eg, patient who cannot return for control visits (e.g. patients living abroad).
Key Trial Info
Start Date :
July 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 5 2018
Estimated Enrollment :
181 Patients enrolled
Trial Details
Trial ID
NCT02308839
Start Date
July 1 2012
End Date
October 5 2018
Last Update
May 22 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier de Dijon
Dijon, France, 21034